OHR Pharmaceutical, Inc.Company Review & Valuation

OHRP
Nasdaq

About OHR Pharmaceutical, Inc.

OHR Pharmaceutical, Inc., a clinical-stage pharmaceutical company, focuses on the development of novel therapies for the treatment of ophthalmic diseases. Its lead clinical program is topical Squalamine, a small molecule anti-angiogenic drug, which could provide a non-invasive therapy to enhance visShow moreion outcomes. The company is evaluating Squalamine in combination with Lucentis injections, which completed Phase II clinical trials for the treatment of retinal diseases, including wet form of age-related macular degeneration, retinal vein occlusion, and diabetic retinopathy. It is also developing a sustained release ocular drug delivery platform technology. OHR Pharmaceutical, Inc. is headquartered in New York, New York.Show less

Industry
Biotechnology
HQ Location
New York, New York

Stock Price

Price data not available for OHR Pharmaceutical, Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

BioTime
Trevena
United Therapeutics
Biofrontera

back to top